The global biopharmaceutical excipients market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for biopharmaceuticals in emerging economies such as China and India, which are witnessing an increase in healthcare expenditure. The increasing number of clinical trials and approvals for new drugs are also driving the growth of this market.
Solubilizers & Surfactants/Emulsifiers: Solubilizers & surfactants/emulsifiers segment accounted for the largest share in 2018 owing to their wide range of applications across various industries such as food, cosmetics, pharmaceuticals, and others. Polyols: Polyols segment accounted for the second-largest share in 2018 owing to their wide range of applications across various industries such as food, cosmetics, pharmaceuticals, and others. Carbohydrates: Carbohydrates segment accounted for the third-largest share in 2018 owing to their wide range of applications across various industries such as food, cosmetics, pharmaceuticals, and others. Biopharmaceutical Downstream: Biopharmaceutical downstream application segment accounted for the largest share in 2018 due to its extensive use by manufacturers who produce drugs or other products that require solvents or other substances that can dissolve or suspend them into a liquid form before they are administered orally or injected into a patient's body through an intravenous line (IV). North America region dominated this market with over 40% revenue contribution followed by Europe region with over 30% revenue contribution during 2017-2030 period.
- The increasing number of clinical trials and rising investments in research and development are also contributing to the growth of this market over the forecast period (2017-2022).
- The growing demand for biologics drugs is also expected to fuel the growth of this market over the forecast period (2017-2022). Biologics drugs are more expensive than traditional small molecule drugs due to their complex manufacturing process which requires excipients with specific properties such as high purity, low toxicity, stability under various conditions, etc, which are not found in traditional excipients used in small molecule drug manufacturing processes. This has led manufacturers of biologics drugs to use specialized excipients that can meet these requirements while maintaining low cost production costs for these products; thereby fueling demand for specialized excipients across all therapeutic areas including oncology, immunology and neurology among others .
Industry Growth Insights published a new data on “Biopharmaceutical Excipients Market”. The research report is titled “Biopharmaceutical Excipients Market research by Types (Solubilizers& Surfactants/Emulsifiers, Polyols, Carbohydrates, Other), By Applications (Biopharmaceutical Downstream, Biopharmaceutical Upstream), By Players/Companies BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries, Signet Chemical Corporation, Spectrum Chemical Manufacturing Corp, SPI Pharma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopharmaceutical Excipients Market Research Report
By Type
Solubilizers& Surfactants/Emulsifiers, Polyols, Carbohydrates, Other
By Application
Biopharmaceutical Downstream, Biopharmaceutical Upstream
By Companies
BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries, Signet Chemical Corporation, Spectrum Chemical Manufacturing Corp, SPI Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Biopharmaceutical Excipients Market Report Segments:
The global Biopharmaceutical Excipients market is segmented on the basis of:
Types
Solubilizers& Surfactants/Emulsifiers, Polyols, Carbohydrates, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Downstream, Biopharmaceutical Upstream
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BASF SE
- ABITEC Corp
- Colorcon, Inc
- DFE Pharma
- Meggle AG
- Pharmonix Biological
- Roquette
- Sigachi Industries
- Signet Chemical Corporation
- Spectrum Chemical Manufacturing Corp
- SPI Pharma
Highlights of The Biopharmaceutical Excipients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solubilizers& Surfactants/Emulsifiers
- Polyols
- Carbohydrates
- Other
- By Application:
- Biopharmaceutical Downstream
- Biopharmaceutical Upstream
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopharmaceutical Excipients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biopharmaceutical excipients are substances that are used in the formulation of pharmaceutical products. These substances may be necessary for the stability of the product or to improve its absorption by the body.
Some of the major players in the biopharmaceutical excipients market are BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries, Signet Chemical Corporation, Spectrum Chemical Manufacturing Corp, SPI Pharma.
The biopharmaceutical excipients market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biopharmaceutical Excipients Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biopharmaceutical Excipients Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biopharmaceutical Excipients Market - Supply Chain
4.5. Global Biopharmaceutical Excipients Market Forecast
4.5.1. Biopharmaceutical Excipients Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biopharmaceutical Excipients Market Size (000 Units) and Y-o-Y Growth
4.5.3. Biopharmaceutical Excipients Market Absolute $ Opportunity
5. Global Biopharmaceutical Excipients Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Biopharmaceutical Excipients Market Size and Volume Forecast by Type
5.3.1. Solubilizers& Surfactants/Emulsifiers
5.3.2. Polyols
5.3.3. Carbohydrates
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Biopharmaceutical Excipients Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Biopharmaceutical Excipients Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Downstream
6.3.2. Biopharmaceutical Upstream
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Biopharmaceutical Excipients Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Biopharmaceutical Excipients Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Biopharmaceutical Excipients Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Biopharmaceutical Excipients Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Biopharmaceutical Excipients Demand Share Forecast, 2019-2029
9. North America Biopharmaceutical Excipients Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Biopharmaceutical Excipients Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Biopharmaceutical Excipients Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Downstream
9.4.2. Biopharmaceutical Upstream
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Biopharmaceutical Excipients Market Size and Volume Forecast by Type
9.7.1. Solubilizers& Surfactants/Emulsifiers
9.7.2. Polyols
9.7.3. Carbohydrates
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Biopharmaceutical Excipients Demand Share Forecast, 2019-2029
10. Latin America Biopharmaceutical Excipients Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Biopharmaceutical Excipients Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Biopharmaceutical Excipients Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Downstream
10.4.2. Biopharmaceutical Upstream
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Biopharmaceutical Excipients Market Size and Volume Forecast by Type
10.7.1. Solubilizers& Surfactants/Emulsifiers
10.7.2. Polyols
10.7.3. Carbohydrates
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Biopharmaceutical Excipients Demand Share Forecast, 2019-2029
11. Europe Biopharmaceutical Excipients Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Biopharmaceutical Excipients Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Biopharmaceutical Excipients Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Downstream
11.4.2. Biopharmaceutical Upstream
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Biopharmaceutical Excipients Market Size and Volume Forecast by Type
11.7.1. Solubilizers& Surfactants/Emulsifiers
11.7.2. Polyols
11.7.3. Carbohydrates
11.7.. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Biopharmaceutical Excipients Demand Share, 2019-2029
12. Asia Pacific Biopharmaceutical Excipients Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Biopharmaceutical Excipients Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Biopharmaceutical Excipients Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Downstream
12.4.2. Biopharmaceutical Upstream
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Biopharmaceutical Excipients Market Size and Volume Forecast by Type
12.7.1. Solubilizers& Surfactants/Emulsifiers
12.7.2. Polyols
12.7.3. Carbohydrates
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Biopharmaceutical Excipients Demand Share, 2019-2029
13. Middle East & Africa Biopharmaceutical Excipients Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Biopharmaceutical Excipients Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Biopharmaceutical Excipients Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Downstream
13.4.2. Biopharmaceutical Upstream
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Biopharmaceutical Excipients Market Size and Volume Forecast by Type
13.7.1. Solubilizers& Surfactants/Emulsifiers
13.7.2. Polyols
13.7.3. Carbohydrates
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Biopharmaceutical Excipients Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Biopharmaceutical Excipients Market: Market Share Analysis
14.2. Biopharmaceutical Excipients Distributors and Customers
14.3. Biopharmaceutical Excipients Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BASF SE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ABITEC Corp
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Colorcon, Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DFE Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Meggle AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pharmonix Biological
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roquette
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sigachi Industries
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Signet Chemical Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Spectrum Chemical Manufacturing Corp
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. SPI Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
